Source link : https://www.newshealth.biz/health-news/flot-protocol-improves-esophageal-cancer-outcomes/
TOPLINE: Perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) demonstrates superior outcomes than preoperative chemoradiotherapy in resectable esophageal adenocarcinoma, with overall survival at 3 years reaching 57.4% vs 50.7%. The median overall survival extends to 66 months with FLOT vs 37 months with preoperative chemoradiotherapy. METHODOLOGY: Two multimodal approaches — preoperative chemoradiotherapy plus surgery […]
Author : News Health
Publish date : 2025-02-04 11:43:30
Copyright for syndicated content belongs to the linked Source.